Cargando…

30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes

It is 30 years since the first diagnostic cancer predisposition gene (CPG) test in the Manchester Centre for Genomic Medicine (MCGM), providing opportunities for cancer prevention, early detection and targeted treatments in index cases and at-risk family members. Here, we present time trends (1990–2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woodward, Emma R., Green, Kate, Burghel, George J., Bulman, Michael, Clancy, Tara, Lalloo, Fiona, Schlecht, Helene, Wallace, Andrew J., Evans, D. Gareth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645350/ https://www.ncbi.nlm.nih.gov/pubmed/34866136 http://dx.doi.org/10.1038/s41431-021-01011-8

Ejemplares similares

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
por: Flaum, Nicola, et al.
Publicado: (2023)

Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
por: Morgan, Robert D., et al.
Publicado: (2023)

Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers
por: Evans, D Gareth, et al.
Publicado: (2022)

Germline FFPE inherited cancer panel testing in deceased family members: implications for clinical management of unaffected relatives
por: Bennett, Sarah, et al.
Publicado: (2021)

Assessment of mismatch repair deficiency in ovarian cancer
por: Crosbie, Emma J, et al.
Publicado: (2021)

Perspectives on the implications of carrying putative pathogenic variants in the medulloblastoma predisposition genes ELP1 and GPR161
por: Smith, Miriam J, et al.
Publicado: (2023)

Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies
por: Ryan, Neil A. J., et al.
Publicado: (2017)

Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
por: Woodward, Emma R., et al.
Publicado: (2021)

Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer
por: Evans, D.Gareth, et al.
Publicado: (2021)

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
por: Evans, D Gareth, et al.
Publicado: (2008)

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status
por: Evans, D G R, et al.
Publicado: (2010)

Impact of free cancer predisposition cascade genetic testing on uptake in Singapore
por: Courtney, Eliza, et al.
Publicado: (2019)

PTCH2 is not a strong candidate gene for gorlin syndrome predisposition
por: Smith, Miriam J., et al.
Publicado: (2021)

Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women
por: Evans, D. Gareth, et al.
Publicado: (2015)

High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer
por: Evans, D Gareth, et al.
Publicado: (2022)

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
por: Antoniou, Antonis C, et al.
Publicado: (2006)

The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathology
por: Lalloo, Fiona, et al.
Publicado: (1999)

Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome
por: Lalloo, Fiona, et al.
Publicado: (2023)

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
por: Hyder, Zerin, et al.
Publicado: (2020)

UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2
por: Hanson, Helen, et al.
Publicado: (2023)

BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study
por: Kitson, Sarah J., et al.
Publicado: (2020)

Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network
por: Garrett, Alice, et al.
Publicado: (2020)

Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol
por: Katapodi, Maria C, et al.
Publicado: (2017)

Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women
por: Evans, D. Gareth, et al.
Publicado: (2021)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
por: Evans, D. Gareth, et al.
Publicado: (2021)

Prescribing cascades in community-dwelling adults: protocol for a systematic review
por: Doherty, Ann, et al.
Publicado: (2021)

Hereditary Predisposition in Phthisis
por: Miller, J. W.
Publicado: (1907)

Hereditary Predisposition to Dipsomania
por: Thomson, J. B.
Publicado: (1858)

Extended gene panel testing in lobular breast cancer
por: van Veen, Elke M., et al.
Publicado: (2021)

Strong Hereditary Predispositions to Colorectal Cancer
por: Hryhorowicz, Szymon, et al.
Publicado: (2022)

Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers.
por: Evans, H J, et al.
Publicado: (1992)

Infection and Predisposition
Publicado: (1901)

Predisposition and Environment
por: Mills, G. Alden
Publicado: (1901)

Prescribing cascades in community‐dwelling adults: A systematic review
por: Doherty, Ann S., et al.
Publicado: (2022)

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels
por: Crosbie, Emma J., et al.
Publicado: (2020)

Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes
por: Whitworth, James, et al.
Publicado: (2018)

Selecting for predisposition to cancer cachexia
por: Gioulbasanis, Ioannis, et al.
Publicado: (2012)

Smoking, Genetic Predisposition, and Colorectal Cancer Risk
por: Chen, Xuechen, et al.
Publicado: (2021)

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study
por: Chandrasekaran, Dhivya, et al.
Publicado: (2021)

The PIRO concept: P is for predisposition
por: Angus, Derek C, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_l5ml7tlhoaio49kus8h2jomj9q